about
Stable isotope-resolved metabolomics and applications for drug developmentMolecular Imaging of Metabolic Reprograming in Mutant IDH CellsMolecular magnetic resonance imaging in cancerMRI for Crohn's Disease: Present and FutureCancer metabolic reprogramming: importance, main features, and potentials for precise targeted anti-cancer therapiesUsing magnetic resonance imaging and spectroscopy in cancer diagnostics and monitoring: preclinical and clinical approachesAn introduction to molecular imaging in radiation oncology: a report by the AAPM Working Group on Molecular Imaging in Radiation Oncology (WGMIR)Imaging metabolic heterogeneity in cancerMetabolic remodeling of malignant gliomas for enhanced sensitization during radiotherapy: an in vitro studyIdentification of Gastric Cancer Biomarkers Using 1H Nuclear Magnetic Resonance SpectrometryEvaluating pH in the Extracellular Tumor Microenvironment Using CEST MRI and Other Imaging MethodsWhole animal imaging.Translational imaging endpoints to predict treatment response to novel targeted anticancer agents.Choline-releasing glycerophosphodiesterase EDI3 drives tumor cell migration and metastasisSodium 3D COncentration MApping (COMA 3D) using (23)Na and proton MRI.pH imaging of mouse kidneys in vivo using a frequency-dependent paraCEST agent.Magnetic Resonance (MR) Metabolic Imaging in Glioma.MR Molecular Imaging of Brain Cancer Metabolism Using Hyperpolarized 13C Magnetic Resonance Spectroscopy.In vivo imaging techniques: a new era for histochemical analysisTemporal and dose dependence of T2 and ADC at 9.4 T in a mouse model following single fraction radiation therapy.Choline PET for monitoring early tumor response to photodynamic therapyDistinct choline metabolic profiles are associated with differences in gene expression for basal-like and luminal-like breast cancer xenograft modelsEvaluations of extracellular pH within in vivo tumors using acidoCEST MRIADC response to radiation therapy correlates with induced changes in radiosensitivity.Activation of phosphatidylcholine cycle enzymes in human epithelial ovarian cancer cells.Liquid Chromatography Mass Spectrometry-Based Metabolite Pathway Analyses of Myeloma and Non-Hodgkin's Lymphoma PatientsAnalysis of metabolic indices in regions of abnormal perfusion in patients with high-grade glioma.Magnetic resonance spectroscopy in metabolic and molecular imaging and diagnosis of cancerCharacterization of breast cancers and therapy response by MRS and quantitative gene expression profiling in the choline pathway.Metabolite detection of pancreatic carcinoma by in vivo proton MR spectroscopy at 3T: initial results.Pancreas oxygen persufflation increases ATP levels as shown by nuclear magnetic resonanceProton Magnetic Resonance Spectroscopy in adult cancer patients with delirium.Analysis of cancer metabolism by imaging hyperpolarized nuclei: prospects for translation to clinical research.Imaging and cancer: a review.Inhibition of Pediatric Glioblastoma Tumor Growth by the Anti-Cancer Agent OKN-007 in Orthotopic Mouse Xenografts.Metabolic tumor imaging using magnetic resonance spectroscopy.Choline kinase alpha-Putting the ChoK-hold on tumor metabolism.Targeted molecular imaging in oncology: focus on radiation therapy.Fatty acid synthase inhibition results in a magnetic resonance-detectable drop in phosphocholine.Molecular imaging as a tool for translating breast cancer science
P2860
Q24629149-01D4B3F0-DA45-4568-98A8-39C24B9D7D5AQ26750861-4A0E2F34-DA0B-4397-9637-DFB95567581BQ26782151-7EC3916D-0B39-48D5-B793-AB8CE9FD6574Q26785603-461E9FCC-0D60-4802-AF1D-0B80A43C056CQ26823118-167E003D-8476-4868-952C-D9B5A6F4DF12Q26865120-A144245C-F4FE-49A6-8F62-2086DFB837A5Q27002845-B9FB3AB7-B80F-4399-BE31-7554C1A654D5Q28076500-91B0C87F-8B67-4887-A89A-C9115930CD14Q28286868-CF3E1E30-97BC-47C1-9A73-CBC5385DA8EAQ28553966-FD19C8ED-B9B1-4499-B218-563DD6EA2B35Q28821895-58BE5BA1-8094-4AF7-B8CD-F347475A5B4EQ30411800-D55D3ED0-F8C8-4E11-BBCE-C1516C22AD7DQ30465097-05507F3F-7E81-4857-A37B-2E143CD68800Q30514230-34D8D230-D2C7-425C-BB5D-E95036BACAC1Q30592717-1BAB6DE2-4FE7-4897-A280-E77F1B3536D6Q30980317-D1501263-2761-453B-B9A7-C9899D9DE038Q31015256-301B1076-AEDC-4039-822D-00C52A5A02CCQ31137181-671FB1A8-86A0-4DED-BDD0-7C213CAE6550Q31154248-4F6539EA-EF6B-4524-B2E5-82D4E6ADFE0BQ33492874-840A73A5-6240-4928-8D2D-E2FF8897900AQ33518345-E1509015-95C1-43E8-B76D-5FDD384AA72FQ33660965-D394091C-69CB-4821-8F97-683EAB5F422FQ33663027-D1E233FA-E2A4-45C4-AE08-5EC8173465ABQ33689750-D691B499-E364-4E55-8C65-A20A07DCF22AQ33699139-8EB19FF0-357C-4B6B-B7C0-C6E512B64277Q33738082-26B616C8-A689-4935-B82E-E7A167C2D585Q33793833-67099289-DD20-460A-A7B8-715EE3B68714Q33881902-FCDDD75E-8EC9-46E0-B9D2-404F193B8A71Q34035237-AD989C08-DAFC-459A-81BB-575B97E3A611Q34077408-8E20C9B7-8601-4491-BAC3-2EACF264F3F3Q34163759-800F59E0-9E39-450C-9E43-96CD0823616BQ34538255-5615CC03-6E6B-42CE-9983-63BA13768A2DQ34551523-7AAB2945-0C78-4009-A5DC-61FB63EAA877Q34977050-3231BA95-56E6-4511-9C71-AB1565A53DF9Q35738941-32A709CC-86A9-47D2-8E92-D1EDFEC3DE61Q35746099-6DE9933F-DA20-4AA9-B743-87C27CE2F7C8Q35987985-B33C64A7-5AD4-4C8E-89D1-1DC180377E8FQ36528175-037447F6-07F7-4F5A-A51B-B7557907BE19Q36908847-A4F26A52-B889-4F69-A3A1-62D81F4DE946Q37019264-8B144C35-6DCA-4C48-A043-BBE578A9F962
P2860
description
2005 nî lūn-bûn
@nan
2005 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
In vivo magnetic resonance spectroscopy in cancer.
@ast
In vivo magnetic resonance spectroscopy in cancer.
@en
type
label
In vivo magnetic resonance spectroscopy in cancer.
@ast
In vivo magnetic resonance spectroscopy in cancer.
@en
prefLabel
In vivo magnetic resonance spectroscopy in cancer.
@ast
In vivo magnetic resonance spectroscopy in cancer.
@en
P1476
In vivo magnetic resonance spectroscopy in cancer
@en
P2093
David L Morse
P304
P356
10.1146/ANNUREV.BIOENG.7.060804.100411
P407
P577
2005-01-01T00:00:00Z